Mayer Brown Advises AstraZeneca On Acquisition
Mayer Brown Rowe & Maw LLP is advising AstraZeneca on the antitrust aspects of its $15.8 billion acquisition of MedImmune Inc., announced on Monday....To view the full article, register now.
Already a subscriber? Click here to view full article